학술논문
Corrigendum to ‘Long-term outcomes of operable stage III NSCLC in the pre-immunotherapy era: results from a pooled analysis of the SAKK 16/96, SAKK 16/00, SAKK 16/01, and SAKK 16/08 trials’: [ESMO Open Volume 7, Issue 2, (2022), 100455]
Document Type
Erratum
Author
Source
In ESMO Open June 2022 7(3)
Subject
Language
ISSN
2059-7029